Back to Ohio

HB401 • 2026

Designate Myositis Awareness Month

Designate Myositis Awareness Month

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Tristan Rader
Last action
Official status
As Introduced
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Designate Myositis Awareness Month

To enact section 5.2323 of the Revised Code to designate May as "Myositis Awareness Month."

What This Bill Does

  • To enact section 5.2323 of the Revised Code to designate May as "Myositis Awareness Month."

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. Ohio Legislature

    As Introduced

Official Summary Text

To enact section 5.2323 of the Revised Code to designate May as "Myositis Awareness Month."

Current Bill Text

Read the full stored bill text
As Introduced

136th
General Assembly

Regular
Session
H. B. No. 401

2025-2026

Representatives Rader, Baker

Cosponsors: Representatives Brownlee,
Piccolantonio, Brennan, Miller, J., Gross, Lett, Robinson, Synenberg,
Brewer, Rogers, Cockley

To
enact section 5.2323 of the Revised Code
to
designate May as "Myositis Awareness Month."

BE
IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

Section
1.
That
section 5.2323 of the Revised Code be enacted to read as follows:

Sec.
5.2323.
The
month of May is designated as "Myositis Awareness Month" in
recognition of the following:

(A)
Idiopathic inflammatory myopathies, collectively referred to as
myositis, are rare, chronic autoimmune muscle-wasting diseases that
often feature debilitating muscle inflammation and other symptoms
such as pain, fatigue, and trouble swallowing, and can result in
myositis-associated interstitial lung disease.

(B)
Myositis contributes to a reduced quality of life and lifespan.

(C)
Myositis is difficult to diagnose, and more research is needed to
identify the causes of, and treatments for, the myositis group of
diseases.